Meet Jen­nifer Pet­ter: Boston start­up Ar­rakis cel­e­brates a big per­son­al tran­si­tion for top ex­ec

A Boston start­up that made this year’s list of promis­ing new biotech ven­tures to watch is cel­e­brat­ing some per­son­al news about one of its founders to­day: its chief sci­en­tif­ic of­fi­cer is trans­gen­der. Al­though known as Russ Pet­ter in the past, she now goes by Jen­nifer Pet­ter.

The com­pa­ny, Ar­rakis Ther­a­peu­tics, is step­ping for­ward to warm­ly ap­plaud her tran­si­tion, start­ing first with a blog writ­ten by its CEO Michael Gilman and post­ed to the com­pa­ny web­site.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.